BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23300966)

  • 1. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
    Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL
    PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index, smoking, and alcohol and risks of Barrett's esophagus and esophageal adenocarcinoma: a UK prospective cohort study.
    Yates M; Cheong E; Luben R; Igali L; Fitzgerald R; Khaw KT; Hart A
    Dig Dis Sci; 2014 Jul; 59(7):1552-9. PubMed ID: 24500448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
    Duggan C; Onstad L; Hardikar S; Blount PL; Reid BJ; Vaughan TL
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):934-43. PubMed ID: 23466711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
    Dong LM; Kristal AR; Peters U; Schenk JM; Sanchez CA; Rabinovitch PS; Blount PL; Odze RD; Ayub K; Reid BJ; Vaughan TL
    Nutr Cancer; 2008; 60(1):39-48. PubMed ID: 18444134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Cook MB; Shaheen NJ; Anderson LA; Giffen C; Chow WH; Vaughan TL; Whiteman DC; Corley DA
    Gastroenterology; 2012 Apr; 142(4):744-53. PubMed ID: 22245667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus.
    Coleman HG; Bhat S; Johnston BT; McManus D; Gavin AT; Murray LJ
    Gastroenterology; 2012 Feb; 142(2):233-40. PubMed ID: 22062359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.
    Spreafico A; Coate L; Zhai R; Xu W; Chen ZF; Chen Z; Patel D; Tse B; Brown MC; Heist RS; Dodbiba L; Teichman J; Kulke M; Su L; Eng L; Knox J; Wong R; Darling GE; Christiani DC; Liu G
    Cancer Epidemiol; 2017 Apr; 47():28-34. PubMed ID: 28088657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of selected risk factors in Barrett's esophagus development].
    Kiciński P; Mokrowiecka A; Czkwianianc E; Kolasa-Kicińska M; Wozniakowska-Gesicka T; Małecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):390-4. PubMed ID: 19606681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
    Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
    Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
    J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus in 2008: an update.
    Wood RK; Yang YX
    Keio J Med; 2008 Sep; 57(3):132-8. PubMed ID: 18854665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases-An endoscopy cross-sectional study.
    Chuang YS; Wu MC; Wang YK; Chen YH; Kuo CH; Wu DC; Wu MT; Wu IC
    Kaohsiung J Med Sci; 2019 Jun; 35(6):341-349. PubMed ID: 31001924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
    Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of lifestyle on Barrett's Esophagus: A precursor to esophageal adenocarcinoma.
    Navab F; Nathanson BH; Desilets DJ
    Cancer Epidemiol; 2015 Dec; 39(6):885-91. PubMed ID: 26519660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus.
    Gray MR; Donnelly RJ; Kingsnorth AN
    Gut; 1993 Jun; 34(6):727-31. PubMed ID: 8314502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus.
    Achkar JP; Post AB; Achkar E; Carey WD
    Am J Gastroenterol; 1995 Jan; 90(1):39-43. PubMed ID: 7801946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.